National Drug Schedules

NOTE - Effective December 19, 2013, Schedule F to the Food and Drug Regulationswas repealed and replaced by a list of prescription drugs, called the Prescription Drug List. Therefore, all entries in the National Drug Schedules (NDS) whose footnote indicates that they appear in Schedule F (F1/F2) should now be considered part of the Prescription Drug List (PDL).

Entries whose footnote indicates that they are "Schedule F Recommended" (FR) should now be considered recommended for addition to the PDL. Some of the "Schedule F Recommended" entries may have been added or will shortly be added to the PDL by Health Canada, but either way these entries will continue to be listed in Schedule I of the NDS.

For more information on the Prescription Drug List, please consult the Health Canada website.

Drug Product Database
Licensed Natural Health Products Database

Print Friendly Export to CSV

Drug Name	Comment	Schedule	Date
Vaccines	(except for - those which are part of a routine immunization program in most/all provinces and territories: Diphtheria toxoid, Tetanus toxoid, Pertussis, Poliomyelitis, Haemophilus influenza type B, Measles, Mumps, Pneumococcus, Rubella, Hepatitis B Pediatric, Influenza, cholera vaccine (oral, inactivated) when used for prophylaxis against traveller's diarrhea & due to enterotoxigenic escherichia coli (ETEC); and those requiring special enhanced public access due to disease outbreaks: Meningococcus)	I	FEB / 02
Vaccines.	which are part of a routine immunization program in most/all provinces and territories: Diptheria toxoid, Tetanus toxoid, Pertussis, Poliomyelitis, Haemophilus influenza type B, Measles, Mumps, Pneumococcus, Rubella, Hepatitis B Pediatric, Influenza, cholera vaccine (oral, inactivated) when used for prophylaxis against traveller's diarrhea & due to enterotoxigenic escherichia coli (ETEC); and those requiring special enhanced public access due to disease outbreaks: Meningococcus	II	FEB / 02
Valaciclovir or its salts		I	DEC / 13
Valdecoxib or its salts		I	DEC / 13
Valganciclovir or its salts or derivatives		I	DEC / 13
Valproic acid or its salts	Including but not limited to Divalproex sodium	I	DEC / 13
Valrubicin or its derivatives		I	DEC / 13
Valsartan or its salts or derivatives		I	DEC / 13
Vancomycin or its salts or derivatives	Including but not limited to Telavancin.	I	DEC / 13
Vandetanib or its salts or derivatives		I	DEC / 13
Vardenafil or its salts		I	DEC / 13
Varenicline or its salts		I	DEC / 13
Varicella Zoster immune globulin		I	FEB / 02
Varicella vaccine (chicken pox)		I	FEB / 02
Vasopressin or its salts		I	DEC / 13
Vecuronium bromide		I	DEC / 13
Vedaprofen or its salts or derivatives		I	DEC / 13
Vedolizumab		I	MAR / 15
Vegetable tar	except shampoos in concentrations of 5% or less	III	SEP / 98
Velaglucerase alfa		I	DEC / 13
Velpatasvir		I	AUG / 16
Vemurafenib or its salts or derivatives		I	DEC / 13
Venetoclax or its salts		I	NOV / 16
Venlafaxine or its salts		I	DEC / 13
Verapamil or its salts		I	DEC / 13
Veratrum album or its alkaloids or their salts	For human use.	I	DEC / 13
Veratrum viride or its alkaloids or their salts	For human use	I	DEC / 13
Vernakalant or its salts		I	APR / 17
Verteporfin or its salts or derivatives		I	DEC / 13
Vidarabine		I	DEC / 13
Vigabatrin or its salts or derivatives		I	DEC / 13
Vilanterol or its salts	Including but not limited to Vilanterol trifenatate	I	DEC / 13
Vilazodone or its salts		I	AUG / 15
Vinblastine or its salts		I	DEC / 13
Vincristine or its salts		I	DEC / 13
Vindesine or its salts		I	DEC / 13
Vinorelbine or its salts		I	DEC / 13
Viomycin or its salts or derivatives		I	DEC / 13
Virginiamycin or its salts or derivatives		I	DEC / 18
Vismodegib		I	DEC / 13
Vitamin A	For human use - in oral dosage forms containing more than 10,000 International Units of Vitamin A per dosage form or, where the largest recommended daily dosage shown on the label would, if consumed by a person, result in the daily intake by that person of more than 10,000 International Units of Vitamin A.	I	DEC / 13
Vitamin B12 with Intrinsic Factor Concentrate		I	DEC / 13
Vitamin D	For human use - in oral dosage form containing more than 1,000 International Units of Vitamin D per dosage form or, where the largest recommended daily dosage shown on the label would, if consumed by a person, result in the daily intake by that person of more than 1,000 International Units of Vitamin D.	I	DEC / 13
Vitamin K	For human use - except Vitamin K1 or Vitamin K2 sold (a) for external use in humans; or (b) in an oral dosage form for use in humans if the maximum recommended daily dose is 0.120 mg or less.	I	DEC / 13
Vitamins	any parenterals not otherwise included in Schedule I	II	SEP / 98
Vitamins in injectable form for parenteral nutrition		I	JAN / 03
Vorapaxar or its salts		I	AUG / 16
Voriconazole		I	DEC / 13
Vorinostat		I	DEC / 13
Vortioxetine or its salts	including but not limited to vortioxetine hydrobromide	I	DEC / 14
Voxilaprevir or its salts		I	SEP / 17

51 result(s)

Print Friendly Export to CSV

Footnotes

C - Drug is listed in the Schedule to Part G of the Food and Drug Regulations under the Controlled Drugs and Substances Act
N - Drug is listed in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
NR - Drug has not been reviewed by the NDSAC
PDL - Drug is listed in the Health Canada Prescription Drug List
TS - Drug is listed in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
CR - Drug has been recommended for addition to the Controlled Drugs and Substances Act

National Drug Schedules

Search: National Drug Schedules

51 result(s)

Footnotes